{"count": 2, "results": [{"_id": "40659125", "pmid": 40659125, "title": "Immunometabolic modulators alleviate vascular dysfunction in mice with systemic lupus erythematosus.", "journal": "Biochem Pharmacol", "authors": ["Miñano S", "Moleón J", "González-Correa C", "Jiménez R", "Gómez-Guzmán M", "Martín-Morales N", "O'Valle F", "Romero M", "Toral M", "Duarte J"], "date": "2025-07-12T00:00:00Z", "doi": "10.1016/j.bcp.2025.117154", "meta_date_publication": "2025 Jul 12", "meta_volume": "241", "meta_issue": "", "meta_pages": "117154", "score": 50240.258, "text_hl": "Moreover, the activation of AMPK in the vascular wall by @CHEMICAL_Deoxyglucose @CHEMICAL_MESH:D003847 @@@2DG@@@ + @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ improved @DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@. ", "citations": {"NLM": "Miñano S, Moleón J, González-Correa C, Jiménez R, Gómez-Guzmán M, Martín-Morales N, O'Valle F, Romero M, Toral M, Duarte J. Immunometabolic modulators alleviate vascular dysfunction in mice with systemic lupus erythematosus. Biochem Pharmacol. 2025 Jul 12;241():117154. PMID: 40659125", "BibTeX": "@article{40659125, title={Immunometabolic modulators alleviate vascular dysfunction in mice with systemic lupus erythematosus.}, author={Miñano S and Moleón J and González-Correa C and Jiménez R and Gómez-Guzmán M and Martín-Morales N and O'Valle F and Romero M and Toral M and Duarte J}, journal={Biochem Pharmacol}, volume={241}, pages={117154}}"}}, {"_id": "31522593", "pmid": 31522593, "title": "Metformin suppresses aortic ultrastrucural damage and hypertension induced by diabetes: a potential role of advanced glycation end products.", "journal": "Ultrastruct Pathol", "authors": ["Dallak M", "Haidara MA", "Bin-Jaliah I", "Eid RA", "Amin SN", "Abdel Latif NS", "Al-Ani B"], "date": "2019-01-01T00:00:00Z", "doi": "10.1080/01913123.2019.1666952", "meta_date_publication": "2019", "meta_volume": "43", "meta_issue": "4-5", "meta_pages": "190-198", "score": 50047.87, "text_hl": "The advanced glycation end products (AGEs) play an important role in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@-mediated @DISEASE_Vascular_System_Injuries @DISEASE_MESH:D057772 @@@vascular injury@@@. We tested whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can suppress aortic AGEs production and protect against @<m>DISEASE_Aortic_Diseases</m> @DISEASE_MESH:D001018 @@@aortic injuries@@@ (aortopathy) and @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ in @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@streptozotocin@@@-induced @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ (@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@) animal model. ", "citations": {"NLM": "Dallak M, Haidara MA, Bin-Jaliah I, Eid RA, Amin SN, Abdel Latif NS, Al-Ani B. Metformin suppresses aortic ultrastrucural damage and hypertension induced by diabetes: a potential role of advanced glycation end products. Ultrastruct Pathol. 2019;43(4-5):190-198. PMID: 31522593", "BibTeX": "@article{31522593, title={Metformin suppresses aortic ultrastrucural damage and hypertension induced by diabetes: a potential role of advanced glycation end products.}, author={Dallak M and Haidara MA and Bin-Jaliah I and Eid RA and Amin SN and Abdel Latif NS and Al-Ani B}, journal={Ultrastruct Pathol}, volume={43}, number={4-5}, pages={190-198}}"}}]}